Novel actions of thrombin-derived host defense peptides
Thrombin-derived C-terminal peptides (TCPs) constitute a novel class of immunomodulatory host defense peptides, generated during infection and inflammation. Previous investigations have shown that TCPs of 2-3 kDa inhibit pro-inflammatory immune responses in vitro and in vivo, but their mode of action remained unclear. Paper I shows that the prototypic TCP GKY25 binds to LPS, thereby preventing TLR
